|
|
|
|
Dr. Paul M. Ridker
Paul M Ridker, MD, MPH, FACC, FAHA
Eugene Braunwald Professor of Medicine, Harvard Medical School
Director, Center for Cardiovascular Disease Prevention
Divisions of Cardiovascular Diseases and Preventive Medicine
Brigham and Women's Hospital
Boston, Massachusetts
Dr. Ridker is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women's Hospital in Boston which focuses on the molecular and genetic epidemiology of cardiovascular diseases.
As a graduate of Brown University, the Harvard Medical School, and the Harvard School of Public Health, Dr. Ridker's primary research brings together classical tools of large-scale, population based epidemiology with emerging genetic and molecular techniques designed to improve our ability to predict and prevent thrombotic occlusion. Particular areas of interest involve molecular and genetic determinants of hemostasis, thrombosis, and inflammation with a focus on "predictive medicine", early disease diagnosis, and the underlying causes and prevention of acute coronary syndromes. Dr. Ridker's research efforts are supported by multiple RO1 research grants from the National Heart, Lung, and Blood Institute (NHLBI) as well a Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation.
Dr. Ridker is also the Principal Investigator of PREVENT, an NHLBI-funded multi-center clinical trial of thrombosis prevention among individuals with and without genetic predispositions to hypercoagulability. Dr. Ridker additionally directs an NHLBI-funded institutional National Research Service Award (training grant) in cardiovascular epidemiology, and Co-Directs the Leducq Center for Cardiovascular Research at the Brigham and Women's Hospital and Harvard Medical School. Dr. Ridker has been the recipient of both a Clinician Scientist Award (1992-1997) and an Established Investigator Award (1997-2002) from the American Heart Association. A frequent invited lecturer at national and international conferences, Dr. Ridker lists among his honors elected membership into the American Society for Clinical Investigation (ASCI), the American Epidemiological Society (AES), and the American Association of Physicians (AAP). Citing his pioneering work on inflammation, C-reactive protein (CRP), and atherothrombosis, Time Magazine honored Dr. Ridker as one of America's Ten Best Researchers in Science and Medicine in 2001. In 2003, Dr. Ridker's work on inflammation and CRP lead to the first set of federal guidelines advocating CRP evaluation as a new method for cardiovascular disease detection. Also in 2003, Dr. Ridker was named as a Reynolds Investigator and as Co-Director of the Reynolds Center for Cardiovascular Research at the Harvard Medical School.
Dr. Ridker is the author of over 190 original reports, 90 reviews and book chapters, and 3 textbooks related to cardiovascular medicine. Dr. Ridker serves on the editorial board of several major journals and is a Consulting Editor for Circulation.
Dr. Ridker is listed as a co-inventor on several patents filed by the Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease.
|
|
|
Presentations by
Dr. Paul M. Ridker
that are available on
CRPhealth.com
|
|
|
|
|
Sign In
Register Now!
